Literature DB >> 1702153

End-plate ion channel block produced by lincosamide antibiotics and their chemical analogs.

C Prior1, J F Fiekers, F Henderson, J Dempster, I G Marshall, R L Parsons.   

Abstract

Five lincosamide compounds were studied for their effects on end-plate currents (epcs), miniature end-plate currents and acetylcholine-induced current fluctuations in the garter snake costocutaneous nerve-muscle preparation. At high concentrations, lincomycin and clindamycin reduced epc amplitude, but analysis of driving functions showed that only with clindamycin was this due solely to changes in epc quantal content. The effect of lincomycin on epc amplitude was exaggerated by rapid channel block during the rising phase of the epc. Clindamycin produced currents with a single exponential decay and single Lorentzian noise spectra. All the other compounds produced currents which decayed as the sum of two exponential components. For lincomycin and epilincomycin, noise spectra consisted of two Lorentzian components. For epiclindamycin and deoxylincomycin, although epcs and miniature end-plate currents decayed with two components, it was not possible to separate two components in the noise spectra. A kinetic analysis of ion channel blocking actions showed only small differences between the two pairs of stereoisomers studied. End-plate ion channel blocking and unblocking rate constants did not vary greatly among the compounds but the end-plate ion channel unblocking rate constant values for the two lincomycin stereoisomers were larger than those for the two clindamycin stereoisomers. Deoxylincomycin exhibited properties similar to those of the clindamycins. It was concluded that lipid solubility, not stereochemical conformation, plays the greater role in determining the ion channel blocking properties within the series, particularly that of the rate of dissociation of the compound from end-plate ion channels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702153

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Clindamycin inhibits nociceptive response by reducing tumor necrosis factor-α and CXCL-1 production and activating opioidergic mechanisms.

Authors:  Felipe F Rodrigues; Marcela I Morais; Ivo S F Melo; Paulo S A Augusto; Marcela M G B Dutra; Sarah O A M Costa; Fábio C Costa; Franciele A Goulart; Alysson V Braga; Márcio M Coelho; Renes R Machado
Journal:  Inflammopharmacology       Date:  2019-11-25       Impact factor: 4.473

Review 2.  Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components.

Authors:  Alison E Barnhill; Matt T Brewer; Steve A Carlson
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

3.  Prejunctional effects of the nicotinic ACh receptor agonist dimethylphenylpiperazinium at the rat neuromuscular junction.

Authors:  S Singh; C Prior
Journal:  J Physiol       Date:  1998-09-01       Impact factor: 5.182

4.  Calcium and neostigmine antagonize gentamicin, but augment clindamycin-induced tetanic fade in rat phrenic nerve-hemidiaphragm preparations.

Authors:  Soo-Il Lee; Jong-Hwan Lee; Seung Cheol Lee; Jung Moo Lee; Ji Hyeon Lee
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

5.  The antagonistic effect of neostigmine on rocuronium-, clindamycin-, or both-induced neuromuscular blocking in the rat phrenic nerve-hemidiaphragm.

Authors:  Seung Soo Kim; Soo-Il Lee; Chan Jong Chung; Seung-Cheol Lee
Journal:  Korean J Anesthesiol       Date:  2011-10-22

6.  Do bupivacaine, clindamycin, and gentamicin at their clinical concentrations enhance rocuronium-induced neuromuscular block?

Authors:  Soo-Il Lee; Ji Hyeon Lee; Sang Yoong Park; Jae-Won Park
Journal:  Korean J Anesthesiol       Date:  2013-04-22

7.  The synergistic effect of gentamicin and clindamycin on rocuronium-induced neuromuscular blockade.

Authors:  Ji Hyeon Lee; Soo-Il Lee; Chan Jong Chung; Jong Hwan Lee; Seung Cheol Lee; So Ron Choi; Ji Na Oh; Jae Young Bae
Journal:  Korean J Anesthesiol       Date:  2013-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.